Relevant bibliographies by topics / Beta-blocker therapy

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers
  6. Reports

Academic literature on the topic 'Beta-blocker therapy'

Author: Grafiati
Published: 4 June 2021
Last updated: 25 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Beta-blocker therapy.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Beta-blocker therapy"

1

Rezakovic, Saida, Mima Georgieva, and Lidija Pocanic. "Psorasis and beta-blocker therapy." Cardiologia Croatica 9, no. 9-10 (2014): 461. http://dx.doi.org/10.15836/ccar.2014.461.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Amadio, Peter, Doyle M. Cummings, and Patricia B. Amadio. "Beta-blocker therapy for hypertension." Postgraduate Medicine 82, no. 8 (1987): 152–59. http://dx.doi.org/10.1080/00325481.1987.11700083.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Reeder, Sara Jones, and Rosemary L. Hoffmann. "Beta-blocker therapy for hypertension." Dimensions of Critical Care Nursing 20, no. 2 (2001): 2–9. http://dx.doi.org/10.1097/00003465-200103000-00001.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

&NA;. "Beta-blocker therapy for hypertension." Dimensions of Critical Care Nursing 20, no. 2 (2001): 10. http://dx.doi.org/10.1097/00003465-200103000-00002.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

&NA;. "Beta-blocker therapy for hypertension." Dimensions of Critical Care Nursing 20, no. 2 (2001): 11–12. http://dx.doi.org/10.1097/00003465-200103000-00003.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Tuman, Kenneth J., and Robert J. McCarthy. "Individualizing beta-Adrenergic Blocker Therapy." Anesthesia & Analgesia 88, no. 3 (1999): 475–76. http://dx.doi.org/10.1213/00000539-199903000-00001.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Tuman, Kenneth J., and Robert J. McCarthy. "Individualizing beta-Adrenergic Blocker Therapy." Anesthesia & Analgesia 88, no. 3 (1999): 475–76. http://dx.doi.org/10.1097/00000539-199903000-00001.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Alsagaff, Mochamad Yusuf, Melly Susanti, Mochammad Thaha, and Christian Jonatan. "Inotropes in Chronic Beta-Blocker Therapy." Pharmacognosy Journal 13, no. 3 (2021): 828–34. http://dx.doi.org/10.5530/pj.2021.13.105.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Poldermans, Don, and Eric Boersma. "Beta-Blocker Therapy in Noncardiac Surgery." New England Journal of Medicine 353, no. 4 (2005): 412–14. http://dx.doi.org/10.1056/nejme058076.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Yang, Bennie, and Jasmine Luzum. "Pharmacogenetic Considerations in Beta-Blocker Therapy." SMART-MD Journal of Precision Medicine 1, no. 2 (2024): e9-e13. http://dx.doi.org/10.69734/hpaezm84.

Full text
Abstract:
Pharmacogenetic testing offers a promising approach to personalizing beta-blocker therapy which is used for a variety of diseases, such as heart failure, myocardial infarction and migraine prophylaxis. The genetic variability in the metabolism and response to beta-blockers such as metoprolol can significantly influence treatment outcomes. Understanding these genetic differences can help optimize therapy and minimize adverse effects. A brief summary of the current guideline and recommendations: Approximately 0.3-6.5% (depending on their ancestry) of patients are CYP2D6 poor metabolizers. CYP2D6
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Beta-blocker therapy"

1

An, Xuebei. "Investigating the Validity of Observational Study Based on Electronic Medical Records and the Effectiveness of Perioperative Beta-Adrenoceptor Therapy to Reduce Postoperative Cardiac Events in Patients Undergoing Major Non-Cardiac Surgery." Case Western Reserve University School of Graduate Studies / OhioLINK, 2012. http://rave.ohiolink.edu/etdc/view?acc_num=case1338996142.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Abarca, Jacob. "The effect of beta-blocker therapy, ACE inhibitor therapy,and digoxin therapy on the risk of hospitalization and resource utilizationamong patients with congestive heart failure enrolled in a managed care organization." Thesis, The University of Arizona, 2001. http://hdl.handle.net/10150/291440.

Full text
Abstract:
Congestive heart failure (CHF) represents the end-stage of all heart disease. The current incidence of CHF in the US is 550,000 cases per year and is expected to increase in the future. Therapy with β-blockers, ACE inhibitors, and digoxin has been associated with a decreased risk of all-cause hospitalization and CHF-related hospitalization in randomized clinical trials. The purpose of this study was to evaluate the effect of beta-blocker, ACE inhibitor, and digoxin therapy on these outcomes and total direct medical costs among patients with CHF enrolled in a managed care plan. Neither therapie
APA, Harvard, Vancouver, ISO, and other styles
3

Becker, Johannes [Verfasser]. "Effekt der Beta-Blocker-Therapie auf die Infektionsrate nach einem ischämischen Schlaganfall / Johannes Becker." Göttingen : Niedersächsische Staats- und Universitätsbibliothek Göttingen, 2021. http://d-nb.info/1233865722/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Schulz, Sabine-Susan. "Untersuchungen zum myokardialen Sauerstoffradikal-Stoffwechsel am Tiermodell 30 - 36 Stunden und 6 Wochen nach Myokardinfarkt unter medikamentöser Therapie mittels Ramipril, Metoprolol und Kombinationstherapie Metoprolol/Ramipril." Doctoral thesis, Humboldt-Universität zu Berlin, Medizinische Fakultät - Universitätsklinikum Charité, 2005. http://dx.doi.org/10.18452/15164.

Full text
Abstract:
An Herzinsuffizienz sind in Deutschland weit mehr als 1 Mio. Menschen erkrankt. Ihre Häufigkeit steigt stetig an. Die Herzinsuffizienz wird als dominierende Herz-Kreislauf-Erkrankung des 21. Jahrhunderts angesehen. Die Hauptursache der Herzinsuffizienz ist die koronare Herzerkrankung besonderes nach stattgehabtem Myokardinfarkt. Sowohl für den akuten Myokardinfarkt als auch für die sich auf dieser Basis entwickelnde Herzinsuffizienz werden Veränderungen im Stoffwechsel der Sauerstoffradikale als pathophysiologisch bedeutsam angesehen. Es wird angenommen, dass als Folge der akuten Myokardischäm
APA, Harvard, Vancouver, ISO, and other styles
5

Atzeni, Andreas [Verfasser]. "Über den Zusammenhang von β-Blocker-Therapie [Beta-Blocker-Therapie] und Gewichtsveränderungen bei Patienten vor und nach Nierentransplantation / vorgelegt von Atzeni, Andreas". 2006. http://d-nb.info/990922162/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Books on the topic "Beta-blocker therapy"

1

Kaum, Heinz-Josef. Beeinflussung des Plasma-Katecholamin-Spiegels durch eine antihypertensive Therapie mit adrenergen Rezeptorenblockern: Vergleich des Alpha-Blockers Prazosin mit dem Beta-Blocker Atenolol bei Patienten mit essentieller Hypertonie unter Ruhe- und unter Belastungsbedingungen. [s.n.], 1987.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Schwartz, Peter J., and Lia Crotti. Monogenic and oligogenic cardiovascular diseases: genetics of arrhythmias—catecholaminergic polymorphic ventricular tachycardia. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780198784906.003.0152.

Full text
Abstract:
Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a rare inherited disorder associated with syncope and sudden death manifesting in the young during sympathetic activation. The electrocardiogram is normal and the heart is structurally normal. The diagnosis is usually made with an exercise stress test that shows a typical pattern of onset and offset of adrenergically induced ventricular arrhythmias. Molecular screening of RyR2, the major CPVT gene, is recommended whenever the suspicion of CPVT is high. If a disease-causing mutation is identified, cascade screening allows pre-sympt
APA, Harvard, Vancouver, ISO, and other styles
3

Suri, Ajay, and Jean R. McEwan. Anti-anginal agents in critical illness. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199600830.003.0037.

Full text
Abstract:
Angina is chest pain resulting from the lack of blood supply to heart muscle most commonly due to obstructive atherosclerotic. Intensive care unit patients are subject to various stresses that will increase the demand on the heart and are in a pro-thrombotic state. Patients in an intensive treatment unit may be sedated and so cardiac ischaemia may be detected by electrocardiogram, haemodynamic monitoring, and echocardiographic imaging of function. These signs may indicate critical coronary perfusion heralding a myocardial infarction and are alleviated by anti-anginal drugs. Beta-blockers and c
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Beta-blocker therapy"

1

Norris, Robin M., and Michael A. Brown. "Intravenous Beta Blocker Therapy for Acute Myocardial Infarction." In Acute Coronary Care 1987. Springer US, 1987. http://dx.doi.org/10.1007/978-1-4613-2337-2_5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Krieglstein, G. K., and B. Scoville. "Eye Irritation Caused by Topical Beta-Blocker Therapy. A New Methodological Screening Approach." In Second European Glaucoma Symposium, Helsinki, May 1984. Springer Netherlands, 1985. http://dx.doi.org/10.1007/978-94-009-5516-5_28.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Sole, Michael J. "Possible Adverse Effects of Catecholamines in Congestive Heart Failure: A Rationale for Beta-Blocker Therapy." In Developments in Cardiovascular Medicine. Springer US, 1987. http://dx.doi.org/10.1007/978-1-4613-2051-7_11.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Gramer, E. "Zur Beta-Blocker-Therapie des Glaukoms." In Beta-Rezeptoren und Beta-Rezeptorenblocker, edited by P. Grosdanoff, F. Kaindl, and O. Kraupp. De Gruyter, 1987. http://dx.doi.org/10.1515/9783110856293-027.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Gramer, E. "Zur Beta-Blocker-Therapie des Glaukoms." In Therapeutische Probleme, Epidemiologie, Toxikologie, Nutzen-Risiko-Abwägung. De Gruyter, 1987. http://dx.doi.org/10.1515/9783111570563-002.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Schuster, J. "Nutzen-Risiko-Abwägungen bei Beta-Blocker-Therapie." In Beta-Rezeptoren und Beta-Rezeptorenblocker, edited by P. Grosdanoff, F. Kaindl, and O. Kraupp. De Gruyter, 1987. http://dx.doi.org/10.1515/9783110856293-044.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Schuster, J. "Nutzen-/Risiko-Abwägungen bei Beta-Blocker- Therapie." In Therapeutische Probleme, Epidemiologie, Toxikologie, Nutzen-Risiko-Abwägung. De Gruyter, 1987. http://dx.doi.org/10.1515/9783111570563-018.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Dienstl, F. "Die aktuelle Beta-Blocker-Therapie der koronaren Herzkrankheit." In Beta-Rezeptoren und Beta-Rezeptorenblocker, edited by P. Grosdanoff, F. Kaindl, and O. Kraupp. De Gruyter, 1987. http://dx.doi.org/10.1515/9783110856293-017.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Rousseau, M. F., C. Hanet, J. P. Desager, and H. Pouleur. "Effects of Long-Term Therapy with the Association of Nisoldipine and a Beta-Blocker on Exercise Tolerance and Coronary Hemodynamics in Patients with Stable Angina: A Comparison with Monotherapy." In Nisoldipine 1987. Springer Berlin Heidelberg, 1987. http://dx.doi.org/10.1007/978-3-642-73010-8_31.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Rahn, K. H. "Einführung in die klinischen Probleme der Beta-Blocker-Therapie." In Beta-Rezeptoren und Beta-Rezeptorenblocker, edited by P. Grosdanoff, F. Kaindl, and O. Kraupp. De Gruyter, 1987. http://dx.doi.org/10.1515/9783110856293-015.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Beta-blocker therapy"

1

Pukkila, Teemu, Matti Molkkari, Matias Kanniainen, et al. "Effects of Beta Blocker Therapy on RR Interval Correlations During Exercise." In 2023 Computing in Cardiology Conference. Computing in Cardiology, 2023. http://dx.doi.org/10.22489/cinc.2023.104.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Morgan-Hughes, Gareth, Rebecca McNally, Stelios Iacovides, et al. "P11 Radiographer led CTCA – the beginning of the end for routine facilitating beta blocker therapy." In British Society of Cardiovascular Imaging Annual Meeting, Bath, 2022. BMJ Publishing Group Ltd and British Cardiovascular Society, 2022. http://dx.doi.org/10.1136/heartjnl-2022-bsci.16.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

McGill, D., J. McGuiness, and N. Ardlie. "PLATELET FUNCTION ASSOCIATED WITH EXERCISE INDUCED MYOCARDIAL ISCHAEMIA: MODIFICATION BY COMBINED BETA-BL0CKER AND CALCIUM ENTRY BLOCKER THERAPY." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643011.

Full text
Abstract:
The relationship between platelet activation and exercise induced myocardial ischaemia is controversial, and the presence of measurable effects of anti-anginal drugs on platelet function requires further clarification. This study addresses these questions in patients with coronary artery disease (CAD), treated with metoprolol and nifedipine. Twenty seven clinically stable males aged 35 to 69 years (mean 53) with proven CAD, ceased all medications for 5 days, were maximally exercised on a treadmill, and then commenced treatment for 4 weeks. They were exercised to the same workload on treatment
APA, Harvard, Vancouver, ISO, and other styles
4

Jachs, M., L. Hartl, D. Schaufler, et al. "Beta blocker therapy seems to reduce systemic inflammation in cirrhotic patients with portal hypertension - a paired HVPG study." In 53. Jahrestagung der Österreichischen Gesellschaft für Gastroenterologie & Hepatologie (ÖGGH) (online). © Georg Thieme Verlag KG, 2020. http://dx.doi.org/10.1055/s-0040-1712296.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Bonomi, Alberto G., Sharon Goldenberg, Gabriele Papini, et al. "Predicting energy expenditure from photo-plethysmographic measurements of heart rate under beta blocker therapy: Data driven personalization strategies based on mixed models." In 2015 37th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC). IEEE, 2015. http://dx.doi.org/10.1109/embc.2015.7320162.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Stefan, Mihaela S., Aruna Priya, Michael Rothberg, Penelope S. Pekow, and Peter Lindenauer. "The Effectiveness And Safety Of Beta-Blocker Therapy For Patients Hospitalized For Acute Exacerbations Of Chronic Obstructive Lung Disease With Underlying Comorbid Ischemic Heart Disease Or Heart Failure." In American Thoracic Society 2012 International Conference, May 18-23, 2012 • San Francisco, California. American Thoracic Society, 2012. http://dx.doi.org/10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a6638.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Beta-blocker therapy"

1

Yang, Hong-Yan, Mei-Li Sun, and Guang-Zhu Su. Effect of beta-blocker therapy on mortality after colorectal cancer surgery: a meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2020. http://dx.doi.org/10.37766/inplasy2020.10.0092.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Beta-blocker therapy' for particular source types:
Journal articles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography